Maria Sainz - 03 Jan 2022 Form 4 Insider Report for AVANOS MEDICAL, INC. (AVNS)

Reporting relationship: Director
Issuer ticker: AVNS
Reported as of: 03 Jan 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Jan 2022, 08:53:49 UTC
Prior SEC filing: 10 Jan 2022
Next SEC filing: 26 May 2022
Source filing: View source filing
Reporting owner signature: /s/ S. Ross Mansbach, attorney-in-fact for Maria Sainz

Key filing fact

Maria Sainz filed Form 4 for AVANOS MEDICAL, INC. (AVNS) on 05 Jan 2022.

Key facts

This page summarizes Maria Sainz's Form 4 filing for AVANOS MEDICAL, INC. (AVNS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 05 Jan 2022, 08:53.

Change

Previous filing in this sequence was filed on 10 Jan 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AVNS transaction

Common Stock

Award

Transaction value: $0
Shares: +5,354
Change %: +19%
Price: $0.000000
Shares after: 33,396
Date: 03 Jan 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents restricted share units issued to the reporting person on January 3, 2022 pursuant to the Avanos Medical, Inc. Outside Directors' Compensation Plan.